"Compared to the best of currently known 90 mAbs, Cl3hmAb has demonstrated superior neutralizing capability. Tested against 43 strains of the virus in 5 independent research institutes worldwide, 95% of the HIV viruses were neutralized at an IC 90 or above, with impressively 2.6 times better neutralization potency than that of the currently best-known antibodies."